Building fruitful development partnerships between companies, governments and researchers will enable the most promising and impactful deployments in healthcare.
Embracing compliance is a continuous process, and investing in agile technologies that streamline workflows—especially in meeting EU MDR and IVDR requirements—is essential, says Lana Feng, Ph.D., CEO-founder of Huma.AI, a pioneer in a human-centered AI.
Healthcare cannot remain reactive to dealing with cybersecurity risks. We must take a new, proactive approach to protecting our users, and our systems must prioritize reducing the extent of reliance on users against unknown threats.
Effective February 7, the agency will conduct inspections across all commodities, as well as mission-critical foreign and domestic inspections.
AI’s arrival in the cardiovascular profession brings a plethora of new opportunities for providing innovative, tailored treatment.
Although the future is exciting, it also poses real challenges. More collaborative initiatives need to take place between drug manufacturers and developers of manufacturing equipment and consumables.
As more healthcare activities take place from home, passive continuous monitoring solutions and new technology such as artificial intelligence will be critical to communications between providers and patients. In addition, new solutions that offer overnight monitoring will play a crucial role in helping to fill the gaps, particularly in assessing patient deterioration or changes in health conditions. The pandemic has forever changed the trajectory of healthcare and specifically virtual care.
The omicron variant of the coronavirus has made clear that the impact of the pandemic is far from over, particularly for health systems and hospitals. The ongoing need to limit close contact between providers and patients means technology will continue to play a key role, but with that increased reliance on technology comes the heightened exposure to cyber risks, as well.
Francisco Partners is acquiring healthcare data and analytics assets from IBM.
Increasing demand for custom surgical implants and growing investment in R&D will help the sector experience significant growth over the next five years.
